about
The elongated first fibronectin type III domain of collagen XIV is an inducer of quiescence and differentiation in fibroblasts and preadipocytesDynamic postprandial hepatic stiffness augmentation assessed with MR elastography in patients with chronic liver disease.Abdominal magnetic resonance elastographyAlleviation of Dimethylnitrosamine-Induced Liver Injury and Fibrosis by Supplementation of Anabasis articulata Extract in RatsIL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in miceCapsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study.Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.The lipoxygenase inhibitor, baicalein, modulates cell adhesion and migration by up-regulation of integrins and vinculin in rat heart endothelial cellsIntra-voxel incoherent motion MRI in rodent model of diethylnitrosamine-induced liver fibrosisImmunohistochemical localisation of PDE5 in rat lung during pre- and postnatal developmentEndothelin and hepatic wound healing.Relationship between oxidative stress levels and activation state on a hepatic stellate cell line.Different profiles of Ca2+ responses to endothelin-1 and PDGF in liver myofibroblasts during the process of cell differentiation.Effect of compound rhodiola sachalinensis A Bor on CCl4-induced liver fibrosis in rats and its probable molecular mechanisms.Effects of endothelin-1 on hepatic stellate cell proliferation, collagen synthesis and secretion, intracellular free calcium concentration.Imbalance of pro- and antifibrogenic genes and bile duct injury in murine Schistosoma mansoni infection-induced liver fibrosis.Effect of Anoectochilus formosanus on fibrosis and regeneration of the liver in rats.Measurement of liver collagen synthesis by heavy water labeling: effects of profibrotic toxicants and antifibrotic interventions.Inhibition of inducible nitric oxide synthase activity prevents liver recovery in rat thioacetamide-induced fibrosis reversal.KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins.Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease.
P2860
Q28269609-52BE837A-8304-483A-BD6C-AD4883F21E7AQ30474570-BCC0427A-A56D-48C8-B50D-E3F3BF4B2B9EQ30476140-9504CF52-EC11-475D-992D-0746AB317269Q34246819-478DAF9D-6C23-4AD1-B215-EF27A1831676Q34577122-356F4046-459C-40A6-ABAF-7BC194A693A6Q36066055-E5A48F34-F966-4436-A388-D1AD0C53B293Q36304061-37976AAD-885B-40C4-927D-B4E783DD072BQ36358079-8495A37E-1DE7-49A2-87F0-983CF26F0DE6Q36913249-FEFDAAAF-3D0B-4C14-9E2F-CBB125F72306Q37314620-73FF9D8C-7B8E-49EB-A75C-CB1F685E50BFQ37855219-566179AA-6433-4346-AD0A-9A83ED8F8D82Q40289429-CD066727-D2C8-4072-AFA2-F47490AEA972Q41590889-5DAB6CF4-1CAF-4370-89DE-AE47C500D891Q43206635-F40CB5D2-F130-4E0F-A3E9-D342295B8418Q43248646-C53EF054-7E08-4129-A34B-0B74FCFAE73CQ43277935-D257663D-FF20-49E1-B315-A3E06B067D10Q45102822-E8F6B67A-B847-4839-9944-393002E87C32Q46341813-9DE83360-7E03-4BB5-AEE0-EDA096DECF89Q46670678-4009FDD5-AEEA-4450-996A-C182FD714205Q48246049-69A9FFF9-2FE8-4CC4-B4D6-E120281D0661Q49719507-462BEDC8-ADC4-4A40-B725-BC6626F4B7C1
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Hepatic fibrosis: from bench to bedside.
@ast
Hepatic fibrosis: from bench to bedside.
@en
type
label
Hepatic fibrosis: from bench to bedside.
@ast
Hepatic fibrosis: from bench to bedside.
@en
prefLabel
Hepatic fibrosis: from bench to bedside.
@ast
Hepatic fibrosis: from bench to bedside.
@en
P1476
Hepatic fibrosis: from bench to bedside.
@en
P2093
Detlef Schuppan
Yury Popov
P304
P356
10.1046/J.1440-1746.17.S3.18.X
P478
17 Suppl 3
P577
2002-12-01T00:00:00Z